Compare NVCT & RDCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NVCT | RDCM |
|---|---|---|
| Founded | 2020 | 1985 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Computer peripheral equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 220.0M | 205.7M |
| IPO Year | N/A | N/A |
| Metric | NVCT | RDCM |
|---|---|---|
| Price | $8.94 | $12.03 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $15.33 | ★ $18.00 |
| AVG Volume (30 Days) | 64.7K | ★ 104.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $12.98 |
| Revenue Next Year | N/A | $11.26 |
| P/E Ratio | ★ N/A | $17.01 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.55 | $9.88 |
| 52 Week High | $11.52 | $15.15 |
| Indicator | NVCT | RDCM |
|---|---|---|
| Relative Strength Index (RSI) | 59.78 | 44.07 |
| Support Level | $8.12 | $10.64 |
| Resistance Level | $9.23 | $13.27 |
| Average True Range (ATR) | 0.52 | 0.74 |
| MACD | -0.00 | -0.03 |
| Stochastic Oscillator | 79.07 | 53.42 |
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
Radcom Ltd Ltd is engaged in providing network intelligence, 5G ready cloud-native, network intelligence solutions for telecom operators transitioning to 5G. The company has a network intelligence solution for 5G namely Radcom ACE. Its products consist of Radcom Network Visibility, Radcom Service Assurance, and Radcom Network Insights. It has offices in Israel, the United States, Brazil, and India. Key revenue is derived from sales in North America.